Stay updated on BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Sign up to get notified when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.

Latest updates to the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page
- Check2 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.9%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check66 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check81 days agoChange DetectedThe web page has undergone significant updates, including the renaming of the study drug from TNT009 to BIVV009 and the addition of a new study part focused on patients with cold agglutinin disease. Additionally, the revision number has been updated to v2.15.0.SummaryDifference50%
Stay in the know with updates to BIVV009 Safety & Activity in Complement Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIVV009 Safety & Activity in Complement Disorders Clinical Trial page.